The US has reached a point where almost half its population is described as being in some way mentally ill, and nearly a quarter of its citizens -- 67.5 million -- have taken antidepressants.
These eye-popping statistics have sparked a widespread, sometimes rancorous debate about whether people are taking far more medication than is needed for problems that may not even be mental disorders.
Studies indicate that 40 percent of all patients fall short of the diagnoses that doctors and psychiatrists give them, yet 200 million prescriptions are still written annually in the US to treat depression and anxiety.
Those who defend such widespread use of prescription drugs insist that a significant part of the population is under-treated and, by inference, under-medicated. Those opposed to such rampant use of drugs note that diagnostic rates for bipolar disorder, in particular, have skyrocketed by 4,000 percent and that overmedication is impossible without over-diagnosis.
To help settle this long-standing dispute, I studied why the number of recognized psychiatric disorders has ballooned so dramatically in recent decades.
In 1980, the Diagnostic and Statistical Manual of Mental Disorders added 112 new mental disorders to its third edition (DSM-III). Fifty-eight more disorders appeared in the revised third (1987) and fourth (1994) editions.
With more than 1 million copies in print, the manual is known as the bible of US psychiatry; certainly it is an invoked chapter and verse in schools, prisons, courts and by mental-health professionals around the world. The addition of even one new diagnostic code has serious practical consequences. What, then, was the rationale for adding so many in 1980?
After several requests to the American Psychiatric Association, I was granted complete access to the hundreds of unpublished memos, letters and even votes from the period between 1973 and 1979, when the DSM-III task force debated each new and existing disorder. Some of the work was meticulous and commendable. But the overall approval process was more capricious than scientific.
DSM-III grew out of meetings that many participants described as chaotic. One observer later remarked that the small amount of research drawn upon was "really a hodgepodge -- scattered, inconsistent and ambiguous."
The interest and expertise of the task force was limited to one branch of psychiatry: neuropsychiatry. That group met for four years before it occurred to members that such one-sidedness might result in bias.
Incredibly, the lists of symptoms for some disorders were knocked out in minutes. The field studies used to justify their inclusion sometimes involved a single patient evaluated by the person advocating the new disease. Experts pressed for the inclusion of illnesses as questionable as "chronic undifferentiated unhappiness disorder" and "chronic complaint disorder," whose traits included moaning about taxes, the weather, and even sports results.
Social phobia (later dubbed "social anxiety disorder") was one of seven new anxiety disorders created in 1980. At first it struck me as a serious condition. By the 1990s experts were calling it "the disorder of the decade," insisting that as many as one in five Americans suffered from it.
Yet the complete story turned out to be rather more complicated. For starters, the specialist who in the 1960s originally recognized social anxiety (London-based Isaac Marks, a renowned expert on fear and panic) strongly resisted its inclusion in DSM-III as a separate disease category.
The list of common behaviors associated with the disorder gave him pause: fear of eating alone in restaurants, avoidance of public toilets and concern about trembling hands. By the time a revised task force added dislike of public speaking in 1987, the disorder seemed sufficiently elastic to include virtually everyone on the planet.
To counter the impression that it was turning common fears into treatable conditions, DSM-IV added a clause stipulating that social anxiety behaviors had to be "impairing" before a diagnosis was possible. But who was holding the prescribers to such standards? Doubtless, their understanding of impairment was looser than that of the task force. After all, despite the impairment clause, the anxiety disorder mushroomed; By 2000, it was the third most common psychiatric disorder in the US, behind only depression and alcoholism.
Over-medication would affect fewer Americans if we could rein in such clear examples of over-diagnosis. We would have to set the thresholds for psychiatric diagnosis a lot higher, resurrecting the distinction between chronic illness and mild suffering. But there is fierce resistance to this by those who say they are fighting grave mental disorders, for which medication is the only viable treatment.
Failure to reform psychiatry will be disastrous for public health. Consider that apathy, excessive shopping and overuse of the Internet are all serious contenders for inclusion in the next edition of the DSM, due to appear in 2012. If the history of psychiatry is any guide, a new class of medication will soon be touted to treat them. Sanity must prevail: if everyone is mentally ill, then no one is.
Christopher Lane is a professor of English at Northwestern University and author of Shyness: How Normal Behavior Became a Sickness.
COPYRIGHT: PROJECT SYNDICATE
Weeks into the craze, nobody quite knows what to make of the OpenClaw mania sweeping China, marked by viral photos of retirees lining up for installation events and users gathering in red claw hats. The queues and cosplay inspired by the “raising a lobster” trend make for irresistible China clickbait. However, the West is fixating on the least important part of the story. As a consumer craze, OpenClaw — the AI agent designed to do tasks on a user’s behalf — would likely burn out. Without some developer background, it is too glitchy and technically awkward for true mainstream adoption,
On Monday, a group of bipartisan US senators arrived in Taiwan to support the nation’s special defense bill to counter Chinese threats. At the same time, Beijing announced that Chinese President Xi Jinping (習近平) had invited Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文) to visit China, a move to make the KMT a pawn in its proxy warfare against Taiwan and the US. Since her inauguration as KMT chair last year, Cheng, widely seen as a pro-China figure, has made no secret of her desire to interact with the Chinese Communist Party (CCP) and meet with Xi, naming it a
A delegation of Chinese Nationalist Party (KMT) officials led by Chairwoman Cheng Li-wun (鄭麗文) is to travel to China tomorrow for a six-day visit to Jiangsu, Shanghai and Beijing, which might end with a meeting between Cheng and Chinese President Xi Jinping (習近平). The trip was announced by Xinhua news agency on Monday last week, which cited China’s Taiwan Affairs Office (TAO) Director Song Tao (宋濤) as saying that Cheng has repeatedly expressed willingness to visit China, and that the Chinese Communist Party (CCP) Central Committee and Xi have extended an invitation. Although some people have been speculating about a potential Xi-Cheng
No state has ever formally recognized the Central Tibetan Administration (CTA) as a legal entity. The reason is not a lack of legitimacy — the CTA is a functioning exile government with democratic elections and institutions — but the iron grip of realpolitik. To recognize the CTA would be to challenge the People’s Republic of China’s territorial claims, a step no government has been willing to take given Beijing’s economic leverage and geopolitical weight. Under international law, recognition of governments-in-exile has precedent — from the Polish government during World War II to Kuwait’s exile government in 1990 — but such recognition